1-4 of 4
Regis J. O'Keefe
Close
Sort by
Journal Articles

In vivo prostaglandin E 2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells

Benjamin J. Frisch, Rebecca L. Porter, Benjamin J. Gigliotti, Adam J. Olm-Shipman, Jonathan M. Weber, Regis J. O'Keefe, Craig T. Jordan, Laura M. Calvi
Journal: Blood
Blood (2009) 114 (19): 4054–4063.
https://doi.org/10.1182/blood-2009-03-205823
Published: 2009
Includes: Supplemental data
Journal Articles

Prostaglandin E2 (PGE2) Treatment Rapidly Increases the Fraction of Non-Dividing Hematopoietic Stem Cells (HSCs)

Rebecca L Porter, Benjamin J Frisch, Regis J O’Keefe, MD, PhD, Laura M Calvi, MD
Journal: Blood
Blood (2008) 112 (11): 73.
https://doi.org/10.1182/blood.V112.11.73.73
Published: 2008
Journal Articles

In Vivo Treatment with Prostaglandin E 2 (PGE2) Selectively Expands Short-Term Hematopoietic Stem Cells.

Benjamin J. Frisch, BS, Jonathan M. Weber, B.S., Rebecca L. Porter, B.S., Benjamin J. Gigliotti, B.S., Julianne N. Smith, Adam J. Olm-Shipman, B.S., Regis J. O’Keefe, M.D., PhD, Craig T. Jordan, PhD, Laura M. Calvi, M.D.
Journal: Blood
Blood (2007) 110 (11): 1254.
https://doi.org/10.1182/blood.V110.11.1254.1254
Published: 2007
Journal Articles

Prostaglandin E 2 (PGE2) Regulates Osteoblastic Jagged1 and Expands Primitive Hematopoietic Cells In Vivo.

Laura M. Calvi, MD, Benjamin J. Frisch, Benjamin J. Gigliotti, Christina A. Christianson, Jonathan M. Weber, Craig T. Jordan, PhD, Regis J. O’Keefe, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 89.
https://doi.org/10.1182/blood.V108.11.89.89
Published: 2006